COVID-19
SGLT2 inhibitors
antimicrobial resistance
beta-lactams
dexamethasone
insulin icodec
statin therapy
type 2 diabetes
Journal
Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
12
2020
accepted:
05
01
2021
entrez:
5
2
2021
pubmed:
6
2
2021
medline:
6
2
2021
Statut:
epublish
Résumé
The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in various fields of medicine also deserve attention. Herein, the Senior Editors of
Identifiants
pubmed: 33542739
doi: 10.7573/dic.2020-12-10
pii: dic-2020-12-10
pmc: PMC7837369
pii:
doi:
Types de publication
Editorial
Langues
eng
Informations de copyright
Copyright © 2021 Anderson SL, Bassetti M, Mangoni AA.
Déclaration de conflit d'intérêts
Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/01/dic.2020-12-10-COI.pdf
Références
N Engl J Med. 2020 Dec 31;383(27):2677-2678
pubmed: 33301245
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
J Immunol. 2020 Sep 15;205(6):1488-1495
pubmed: 32699160
Drugs Context. 2020 Aug 24;9:
pubmed: 32922503
N Engl J Med. 2020 Jul 16;383(3):207-217
pubmed: 32668111
PLoS Med. 2020 Sep 17;17(9):e1003293
pubmed: 32941437
Eur J Clin Invest. 2020 Oct;50(10):e13362
pubmed: 32726868
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684
pubmed: 32433765
N Engl J Med. 2020 Dec 2;:
pubmed: 33264556
N Engl J Med. 2020 Nov 5;383(19):1838-1847
pubmed: 32865380
Diabetes Obes Metab. 2021 Feb;23(2):549-560
pubmed: 33145944
BMJ. 2020 Jul 30;370:m2980
pubmed: 32732190
Eur J Clin Invest. 2020 Dec;50(12):e13423
pubmed: 33026101
N Engl J Med. 2020 Dec 3;383(23):2219-2229
pubmed: 33264825
N Engl J Med. 2020 Nov 26;383(22):2107-2116
pubmed: 32960514
N Engl J Med. 2020 Jul 17;:
pubmed: 32678530
N Engl J Med. 2020 Oct 29;383(18):1735-1745
pubmed: 32865374
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8143-E8152
pubmed: 30104387
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Eur J Clin Invest. 2020 Mar;50(3):e13209
pubmed: 32003000
J Am Coll Cardiol. 2019 May 14;73(18):2345-2353
pubmed: 31072579
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Am J Nephrol. 2019;50(5):345-356
pubmed: 31665733
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Antibiotics (Basel). 2020 Sep 22;9(9):
pubmed: 32971809
Eur J Clin Invest. 2021 Feb;51(2):e13465
pubmed: 33251590
Am J Health Syst Pharm. 2017 Feb 1;74(3):117-129
pubmed: 28122753
Lancet. 2020 Sep 12;396(10253):759-769
pubmed: 32871100
Curr Opin Infect Dis. 2020 Dec;33(6):495-500
pubmed: 33009142